Company Search:
Advanced Search
Sponsored Links
American Vietnamese Biotech Inc Company Snapshot
American Vietnamese Biotech Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares American Vietnamese Biotech Inc with three other companies in this sector in Vietnam: Vidipha Central Pharmaceutical JSC (2018 sales of 484.93 billion Dong [US$20.90 million] ), Cai Lay Veterinary Pharmaceutical JSC (134.58 billion Dong [US$5.80 million] ), and Central Pharmaceutical JSC No2 (149.69 billion Dong [US$6.45 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
American Vietnamese Biotech Inc
  Stock Performance Chart for American Vietnamese Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 19,300
(Figures in Dong)
1 Week 3.8%   13 Weeks 2.7%  
4 Weeks 9.0%   52 Weeks -24.1%  
American Vietnamese Biotech Inc Key Data:
  Ticker: AMV Country: Vietnam
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 450,796,199,296
(Year Ending Jan 2019).
Employees: N/A
  Currency: Dong Market Cap: 732,667,468,500
  Fiscal Yr Ends: December Shares Outstanding: 37,962,045
  Share Type: Closely Held Shares: 21,527,800
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.